Story

Procter & Gamble to Acquire Supplements Maker Thorne in Health Market Push

ENTHMSVIIDZHZH-TWJAKOHI
Aug 4, 20261 min read
Procter & Gamble to Acquire Supplements Maker Thorne in Health Market Push
Text size
Background

Consumer goods giant Procter & Gamble (NYSE:PG) will acquire supplements manufacturer Thorne, P&G CEO Shailesh Jejurikar confirmed in a Tuesday interview with CNBC. The acquisition marks a significant strategic move for the company, pushing it further into the high-growth health and wellness market.

Deal Valuation and Terms

While the specific financial terms of the deal were not disclosed, Jejurikar stated the acquisition price is favorable. "What I can say is the price is a good price for the growth rates they have. It’s kind of in line with the industry benchmarks we’ve seen," he told CNBC.

A June report from the Financial Times had valued Thorne at up to $4 billion. The final acquisition price has not yet been made public.

Sample IUX Markets – In-articleAd

Strategic Context

The move to acquire Thorne allows Procter & Gamble to diversify its extensive portfolio of consumer brands into the lucrative supplements category. The health and wellness sector has seen sustained investor interest, and Thorne was reportedly a competitive asset.

According to a Reuters report from June, UK-based consumer health company Haleon (NYSE:HLN) was also in the bidding process for Thorne. P&G's successful acquisition positions it to compete more directly in the personal health and vitamins space.

Read next

More on Stocks
Back to latest news

LATEST